Skip to main content

Philips, Teladoc Health team up to offer virtual care solutions in Australia and New Zealand – Mobihealth News

US-based healthcare IT firms Royal Philips and Teladoc Health have joined hands to deliver virtual care solutions in Australia and New Zealand.

WHAT IT’S ABOUT

The two global healthcare IT firms will combine their virtual care offerings to offer hospitals and health systems a scalable end-to-end virtual care service that allows them to conduct remote patient monitoring across health facilities with limited clinical resources.

Philips’ enterprise virtual care solutions leverage monitoring, machine learning and advanced analytics programming to turn disparate data into actionable insights to support clinical decisions. The company claims that this package can reduce patient’s length of stay by 30%, discharge patients 15% faster and reduce patient mortality by 26%. 

Teladoc Health’s virtual care platform and solutions, on the other hand, includes point-of-care devices and solutions that integrate with existing systems and workflows, enabling hospitals to extend their reach to more care sites and impact health and satisfaction outcomes.

In addition, “new patient insights derived from the virtual care models will ensure practitioners are able to deliver patients improved access to specialist care regardless of time or location,” according to a press release.

WHY IT MATTERS

Health networks across Australia and New Zealand are dealing with overwhelmed emergency departments, ICU capacity and backlogs of elective surgery, causing long waiting times for patients. 

Given this, Philips and Teladoc are extending their virtual care solutions with the aim of enhancing patient access to healthcare services, as well as improving clinician experience and patient health outcomes, while reducing the overall cost of care. As of September, these integrated solutions have been made available for public and private health networks in ANZ.

THE LARGER TREND

Early in the year, Teladoc started piloting its virtual primary care programme called Teladoc Primary 360 with large employer health plan clients. In January, the company said it will be rolling out the package in “more commercial populations” throughout 2021. 

Teladoc has also partnered with Microsoft to offer hospitals and health systems its Solo platform via Teams. This integrated feature, which is reported to become available early next year, will provide clinicians access to clinical data within their EHR system without leaving the Teams communication platform.

In other news, Philips has added two new products to its HealthSuite digital platform: one is the patient flow feature that helps clinicians manage patients across the care spectrum, and the other is an acute telehealth product that assists health systems to manage informatics associated with virtual care.

ON THE RECORD

“Philips and Teladoc Health will be a powerful combination for health systems in Australia and New Zealand. Together we will deliver what hospitals and health systems want: integrated, enterprise solutions that make the full breadth of virtual care available to their physicians and patients. Our collaboration will deliver a more seamless, unified experience for clinicians that makes healthcare better, leveraging leading data, analytics and expertise from both companies,” said Darren Reynolds, managing director of Teladoc Health ANZ.

“This partnership with Teladoc strengthens our existing capability through the delivery and performance of best practice programs found at some of the top academic medical institutions and government health systems in the world. We are confident this comprehensive offering will better serve our health systems in Australia and New Zealand,” Shehaan Fernando, regional director of Virtual Care at Royal Philips, also commented.



from WordPress https://ift.tt/3ikgF06
via IFTTT
Labels:

Comments

Post a Comment

Popular posts from this blog

Covid-19 News: F.D.A. Panel to Meet This Week on Moderna and J. & J. Boosters – The New York Times

Image A vaccination site in Spain, where the health regulator approved the use of third Covid-19 vaccination shots for immunocompromised people in September. Credit… Zowy Voeten/Getty Images Severely or moderately immunocompromised people who have been vaccinated should be offered an additional dose of the seven coronavirus vaccines the World Health Organization has authorized, an advisory committee recommended on Monday. People whose immune systems are diminished should get another shot if they initially received vaccines made by Pfizer-BioNTech, Moderna, AstraZeneca, the Serum Institute of India, Johnson & Johnson, Sinopharm and Sinovac, members of the Strategic Advisory Group of Experts on Immunization told reporters on a call on Monday. Dr. Alejandro Cravioto, the committee’s chair, said that people with compromised immune systems “need a third dose as an additional priming process so that they’re fully protected.” The officials also recommended a third vaccine ...
Post a Comment
Read more

COVID-19 live updates: Pfizer to seek approval for adult boosters, source says – WOKV

NEW YORK — As the COVID-19 pandemic has swept the globe, more than 5 million people have died from the disease worldwide, including over 756,000 Americans, according to real-time data compiled by Johns Hopkins University’s Center for Systems Science and Engineering. Just 68.4% of Americans ages 12 and up are fully vaccinated against COVID-19, according to data from the U.S. Centers for Disease Control and Prevention. Latest headlines: -US surgeon general releases guide to combating COVID-19 vaccine misinformation -Pfizer to request OK for boosters to all adults: Source -US reopens borders to vaccinated travelers Here’s how the news is developing. All times Eastern. Nov 09, 2:42 pm Aaron Rodgers: ‘To anybody who felt misled … I take full responsibility’ Green Bay Packers quarterback Aaron Rodgers says he takes full responsibility for anyone who felt mislead by his comments about his vaccination status. “I do realize I am a role model,” Rodgers said on “The Pat McAfee Show” Tu...
Post a Comment
Read more

The F.D.A. is aiming to give full approval to Pfizer’s Covid vaccine on Monday. – The New York Times

Coronavirus Updates Aug. 21, 2021 Updated  Aug. 21, 2021, 10:11 p.m. ET Aug. 21, 2021, 10:11 p.m. ET Pfizer vaccines were administered at the St. John Chrysostom Catholic Parish in The Bronx on Sunday. Credit… James Estrin/The New York Times The Food and Drug Administration is pushing to approve Pfizer-BioNTech’s two-dose Covid-19 vaccine on Monday, further expediting an earlier timeline for licensing the shot, according to people familiar with the agency’s planning. Regulators were working to finish the process by Friday but were still working through a substantial amount of paperwork and negotiation with the company. The people familiar with the planning, who were not authorized to speak publicly about it, cautioned that the approval might slide beyond Monday if some components of the review need more time. An F.D.A. spokeswoman declined to comment. The agency had recently set an unofficial deadline for approval of around Labor Day. The approval is expected to ...
Post a Comment
Read more